Citius Pharmaceuticals (NASDAQ:CTXR) reported quarterly losses of $(0.02) per share. This is a 66.67 percent increase over losses of $(0.06) per share from the same period last year.
Related Posts
CarParts.com Q4 EPS $(0.11), Inline, Sales $154.52M Beat $151.18M Estimate
CarParts.com (NASDAQ:PRTS) reported quarterly losses of $(0.11) per share which met the analyst consensus estimate. This is a 10 percent decrease over losses of $(0.10) per share from the same period last year. The
Credit Suisse Initiates Coverage On Corning with Neutral Rating, Announces Price Target of $36
Credit Suisse analyst Shannon Cross initiates coverage on Corning (NYSE:GLW) with a Neutral rating and announces Price Target of $36.
Melco Announced Provisional Award of 10-Year Gaming Concession in Macau
Melco Resorts & Entertainment Limited (Nasdaq: MLCO) ("Melco" or the "Company"), a developer, owner and operator of integrated resort facilities in Asia and Europe, today announces that the Macau government has provisionally awarded a ten-year concession to operate games of fortune and chance in casinos in Macau to Melco Resor